coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    East Herefordshire PCN, Herefordshire, County of (LAD) · Health Inequalities Profile

    PCN U12199 · NHS Herefordshire and Worcestershire Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    30,434

    Registered population

    52.5% aged 18–64

    32.5%

    Aged 65+

    ICB 24.3% · England 17.9%

    2.4%

    Ethnic minority (non-White)

    0.8% Asian · England 9.6%

    6.0%

    In IMD quintile 1

    ICB 10.9% · England 21.0%

    ~1,713

    Core20 residents (est.)

    Resident basis; registered basis ~1,876 · see page 3

    6,432

    Hypertension register

    +11.78% in 3 yrs · England +5.60%

    246

    SMI register

    14.3% of Herefordshire, County of (LAD)'s

    767

    COPD register

    Reviews -2.11% in 3 yrs

    Forecast to 2030

    8,238

    Hypertension patients, 2030

    +1,806 on today

    70.1%

    QRISK ≥20% on statins, 2030

    +4.73pp over 3 yrs

    8.3%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    67.3%
    Diabetes and high-risk statin coverage trails England.

    Diabetes statin treatment without CVD is 67.3% (England 73.2%, falling 4.5% vs England +2.1%) and QRISK ≥ 20% lipid therapy is 59.4% (England 63.6%).

    72.0%
    COPD review coverage fell behind national growth.

    COPD annual review coverage fell 2.1% to 72.0% (England +2.8%, 76.4%), alongside an estimated 695 asthma patients without a recorded 12-month review.

    91.3%
    SMI physical health checks outpace national rates.

    SMI BMI recording rose +16.4 pp to 91.3% (England +5.1 pp, 82.1%) and blood pressure checks reached 89.9% (England 83.4%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Adults aged 65+ comprise 32.5% of registrations, substantially above national benchmarks

    Across 30,434 registered patients, 32.5% (9,901) are aged 65+, above Herefordshire (28.3%), the ICB (24.3%), and England (17.9%), which may increase frailty service need. Children aged 0–17 make up 14.9% (4,549), below Herefordshire (16.5%), the ICB (17.8%), and England (19.6%). Catchment Census data record 97.6% White residents against Herefordshire (96.9%), the ICB (94.6%), and England (81.1%), with a 2.4% non-White minority share. These Census figures reflect area residents rather than registered patients, while a 2.0% projected list growth to 2030 uses unverified methodology.

    Age profile

    0–1714.9%
    18–6452.5%
    65+32.5%

    65+: ICB 24.3%, England 17.9%

    Ethnicity

    White97.6%
    Mixed0.9%
    Asian0.8%
    Other0.5%
    Black0.2%

    Older people · falls rows are Herefordshire, County of (LAD) local-authority (LA) data, not PCN

    MeasureLocalWest MidlandsEnglandPeriod
    Falls admissions, 65+, per 100,000 (Herefordshire LA)1,4721,8471,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)83.3%—81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)60.0%—57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Herefordshire LA)7729229552024/25
    Falls deaths, all ages, per 100,000 (Herefordshire LA)10.417.514.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 6.0% network-wide and concentrates entirely at Nunwell Surgery

    East Herefordshire PCN has a 6.0% Core20 share, below Herefordshire (7.8%), the ICB (10.9%) and England (21.0%). Average IMD decile is 5.7, compared to 5.5 in Herefordshire, 6.1 in the ICB and 5.5 in England. A reconciliation check shows the modelled weighted practice Core20 share of 6.2% differs from the 6.0% PCN rate by 0.13 percentage points. Deprivation is highly concentrated: Nunwell Surgery holds a 19.5% share (1,876 estimated patients), whereas Ledbury Health Partnership, Colwall Surgery and Cradley Surgery record 0.0%.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Nunwell19.5% · 1,876 patients
    Ledbury Health0.0% · 0 patients
    Colwall0.0% · 0 patients
    Cradley0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    246

    SMI register

    0.82% recorded prevalence

    193

    Learning disability register

    0.64% recorded prevalence

    22

    Care homes, 576 beds

    In the PCN catchment

    8.7%

    Provide unpaid care

    Herefordshire, County of (LAD), Census 2021

    The PCN records 246 patients on the severe mental illness register (0.8%; England 1.0%) and 193 on the learning disability register (0.6%; England 0.6%), alongside 22 catchment care homes with 576 beds. At borough level, the autumn 2025 rough sleeping snapshot recorded 16 people, while an 8.7% Census unpaid care rate provides an estimated ceiling of 2,648 unpaid carers.

    Severe mental illness: physical health checks

    Recorded SMI physical checks exceed comparators: 91.3% had BMI recorded (England 82.1%) and 89.9% had blood pressure checked (England 83.4%). Missing check elements cannot imply completed reviews. Comprehensive physical health checks require auditing uncaptured elements.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,432

    Hypertension register

    +11.78%

    Register growth, 3 yrs

    Herefordshire, County of (LAD) +10.36% · England +5.60%

    −1.29pp

    BP control, under 80

    ≤140/90 · −2.40pp aged 80+

    +1,806

    More patients by 2030

    Forecast 8,238 (26.68%)

    Hypertension case-finding and control

    Hypertension prevalence is 21.4% (6,432 patients), above Herefordshire (19.2%), the ICB (18.7%) and England (15.2%), with a three-year change of +11.8% over 2023 to 2025 (England +5.6%). Although recent blood pressure recording reaches 92.5% (England 90.0%), treatment to target fell 1.8% over three years to 71.4% (England +3.6%), and control in patients aged 80+ is 79.2%, trailing England (81.2%) after falling 2.9% (England +2.2%). Age-unadjusted prevalence may reflect an older demography rather than confirmed case-finding. Trailing national benchmarks on blood pressure control in older cohorts suggests clinical review and medication titration could help improve control.

    Lipids and statins

    Statin coverage in diabetes without CVD is 67.3%, below Herefordshire (72.0%), the ICB (70.8%) and England (73.2%), falling 4.5% over three years (England +2.1%). QRISK ≥ 20% treatment is 59.4% (England 63.6%). Lower coverage than England across diabetic and high-risk cohorts suggests an opportunity to audit lipid therapy uptake.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202676,781£2.60£2.17£1.86£199,631
    Cardiovascular (all), 2025100,610£4.02£4.41£3.33£404,452

    In 2026, the PCN prescribed 76,781 lipid-modifying items at £2.60 per item, above Herefordshire (£2.44), the ICB (£2.17) and England (£1.86), spending £56,818 more than at England's unit cost. This indicator reflects unit cost differences rather than efficiency; local prescribing audits would test if formulary choices explain the variation.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +7.76%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +3.06%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 2.5% (767 patients; England 1.9%, ICB 2.2%), but 12-month COPD reviews fell 2.1% over three years to 72.0% (England +2.8% to 76.4%, ICB 76.8%). Smoking cessation support offered is 88.7% (England 94.2%). Recorded asthma prevalence is 7.9% (2,275 patients; England 6.6%), with 69.5% reviewed (England 65.7%), leaving about 700 patients unreviewed. Furthermore, asthma prescribing for ages 5-19 is 1,843 items per 1,000 (England 1,488). Slipping COPD reviews and high youth prescribing suggest proactive respiratory recall and inhaler reviews could be prioritized.

    Cancer register and children's immunisation

    Cancer: QOF prevalence (all ages) is 6.1% at PCN level, above Herefordshire, County of (LAD) (5.3%), above NHS Herefordshire and Worcestershire Integrated Care Board (5.1%) and above England (3.8%). This is above the comparator, which may reflect demography or recording; crude prevalence does not establish unmet need.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months89.4%

    England 91.0%

    6-in-1 complete primary course at 24 months96.1%

    England 92.2%

    MMR dose 1 at 24 months98.0%

    England 88.3%

    MMR dose 2 at age 594.3%

    England 82.8%

    4-in-1 pre-school booster at age 594.3%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    56.2%

    Herefordshire and Worcestershire ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~770

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Herefordshire and Worcestershire ICBEnglandNo usable stageStaged cancers
    Prostate52.4%53.2%23%706
    Bowel51.4%47.0%15%657
    Breast88.9%85.4%28%611
    Lung32.1%33.8%13%473
    Skin cancer86.3%87.8%13%314

    In 2022, 56.2% of staged cancers across NHS Herefordshire and Worcestershire ICB were diagnosed at stage 1 or 2, 0.9 percentage points above England (55.3%) but 18.8 pp below the 75.0% national ambition. Known stage was recorded for 68.0% of cancers (4,068 of 5,984), and early-stage share fell 2.7 pp between 2013 and 2022. Closing the gap to the 75% ambition required 766 extra early diagnoses across the ICB. These figures reflect system performance, not the PCN. Locally, cervical screening in women aged 25 to 49 is 68.8%, trailing the ICB benchmark of 70.9%, with Ledbury Health Partnership at 64.9% and Nunwell Surgery at 68.3%.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In provisional July 2026 data, Wye Valley NHS Trust met the 85.0% 62-day cancer standard at 85.1%, ahead of Gloucestershire Hospitals NHS Foundation Trust (74.6%), Worcestershire Acute Hospitals NHS Trust (53.0%), the ICB (61.7%) and England (71.2%). Its 28-day faster diagnosis reached 86.5% (ICB 83.0%; England 79.3%) and 31-day treatment reached 96.2% (standard 96.0%). For Wye Valley NHS Trust, 6+ week diagnostic waits reached 40.0% for colonoscopy (England 30.8%) and 48.7% for flexi sigmoidoscopy (England 32.1%). Trust metrics describe wider provider activity rather than PCN-specific performance.

    Pathways within standard (%)Wye ValleyWorcestershire AcuteGloucestershireHerefordshire and Worcestershire ICBEngland
    28-day faster diagnosis (75%)86.5282.5074.4383.0579.32
    31-day treatment (96%)96.2586.9894.6689.9592.50
    62-day referral to treatment (85%)85.1452.9974.5961.7171.16
    Diagnostic waits over 6 weeks (%)Wye ValleyWorcestershire AcuteGloucestershireEngland
    MRI18.2322.5115.9621.40
    CT0.1611.097.449.92
    Echocardiography30.2410.2556.1728.48
    Colonoscopy40.009.9140.0030.83
    Gastroscopy26.099.5331.5529.02
    All 15 DM01 tests19.3530.6118.3423.14
    Community services activityHerefordshire, County of residentsHerefordshire and Worcestershire ICB
    Care contacts43,135124,085
    Referrals5,97023,130
    Patients with a contact9,55030,665

    Community services (residents of Herefordshire, County of), Jun 2026 (provisional). In provisional June 2026 community services data, contacts with adults aged 65 and over accounted for 67.4% of all community contacts among Herefordshire residents (29,080 of 43,135). These figures capture activity across local authority residents rather than registered PCN patients.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Patient phone access spans 49.6 percentage points across member practices

    In 2025/26, clinical QOF achievement was 99.9% at Colwall Surgery and 100.0% at the other three practices (England 97.1%). Overall points exceeded England (92.5%), reaching 93.5% to 97.4%. Vaccination achievement spanned 34.0 pp, from 43.1% at Ledbury Health Partnership to 77.1% at Cradley Surgery (England 55.2%). High clinical scores mask wide variation in immunisation coverage.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Cradley Surgery1200.093.0%70.3%95.4%
    Nunwell Surgery10919.587.6%77.8%93.1%
    Colwall Surgery1300.084.0%69.2%80.7%
    Ledbury Health1110.043.4%81.6%62.3%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNHerefordshire, County of (LAD)AssetPCNHerefordshire, County of (LAD)
    Care homes (catchment)22 (576 beds)n/aSchools (catchment)47n/a
    Children's centres27Places of worship83341
    Libraries29Day centres (VCS)11
    Carers support groups (VCS)n/a1Primary schools (LA maintained)643
    Primary academies1028Special schools34

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured respiratory recall and inhaler reviews

    COPD reviews fell 2.1% over 2023 to 2025 to 72.0% (England +2.8%, 76.4%), smoking cessation support is 88.7% (England 94.2%), and 69.5% asthma review coverage across 2,275 patients leaves 695 (about 700) unreviewed. Moderate effort to run.

    Evidence base: delivery measure for spirometry-confirmed diagnosis; shortfall here is what shows up later as emergency admission.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Option 2

    Pharmacist-led lipid therapy and formulary review

    Statin therapy in diabetes (40+ without CVD) fell 4.5% over 2023 to 2025 to 67.3% (England +2.1%, 73.2%), with CVD is 76.5% (England 84.4%), and QRISK >= 20% lipid therapy is 59.4% (England 63.6%). Moderate effort to run.

    Evidence base: delivery measure for eight care processes and three treatment targets; shortfall here is what shows up later as emergency admission.

    Policy anchor: NHS Diabetes Prevention Programme and the eight care processes / three treatment targets.

    Option 3

    Hypertension titration audit for older adults

    Across 6,432 hypertension patients (21.4%; England 15.2%), treatment to target fell 1.8% over 2023 to 2025 to 71.4% (England +3.6%), and control in patients aged 80+ fell 2.9% to 79.2% (England +2.2%, 81.2%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult proactive care planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 health outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Sustain SMI physical health checks (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension control audit (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Targeted cervical screening recall outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephony review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured respiratory recall and inhaler reviews (p12)COPD patients with a review in the last 12 months · Patients with COPD who had a review in the last 12 months (denominator incl. PCAs) · Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Pharmacist-led lipid therapy and formulary review (p12)Patients with diabetes (40+ yrs no history of CVD) treated with a statin (denominator incl. PCAs) · Patients with diabetes and a history of CVD (excl. haem. stroke) treated with a statin (denominator incl. PCAs) · Patients with QRISK ≥ 20% treated with lipid lowering therapyNHS Long Term Plan (diabetes) and National Diabetes AuditPCN
    Option 3 · Hypertension titration audit for older adults (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15